Monitoring of the Alcohol Biomarkers PEth, CDT and EtG/EtS in an Outpatient Treatment Setting
about
Fetal alcohol-spectrum disorders: identifying at-risk mothersBiomarkers for detection of alcohol consumption in liver transplantationDiagnosis of alcoholic liver disease.Counselling for Alcohol Problems (CAP), a lay counsellor-delivered brief psychological treatment for harmful drinking in men, in primary care in India: a randomised controlled trial.Hangover research needs: proceedings of the 5th Alcohol Hangover Research Group meetingHow accurate are blood (or breath) tests for identifying self-reported heavy drinking among people with alcohol dependence?Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?Use of continuous transdermal alcohol monitoring during a contingency management procedure to reduce excessive alcohol use.Accounting for sex-related differences in the estimation of breath alcohol concentrations using transdermal alcohol monitoringDetermining ethyl glucuronide cutoffs when detecting self-reported alcohol use in addiction treatment patients.Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver diseaseThe validity of phosphatidylethanol in dried blood spots of newborns for the identification of prenatal alcohol exposureHigh levels of agreement between clinic-based ethyl glucuronide (EtG) immunoassays and laboratory-based mass spectrometry.Biomolecules and Biomarkers Used in Diagnosis of Alcohol Drinking and in Monitoring Therapeutic Interventions.Validation of the MINI (DSM IV) Tool for the Assessment of Alcohol Dependence among Young People in Northern Tanzania Using the Alcohol Biomarker Phosphatidylethanol (PEth)The feasibility and cost of neonatal screening for prenatal alcohol exposure by measuring phosphatidylethanol in dried blood spots.Characterization of the Pharmacokinetics of Phosphatidylethanol 16:0/18:1 and 16:0/18:2 in Human Whole Blood After Alcohol Consumption in a Clinical Laboratory Study.Assessing the drinking status of liver transplant patients with alcoholic liver disease.Binge Drinking Episodes in Young Adults: How Should We Measure Them in a Research Setting?Treatment of Alcohol Use Disorder in Patients with Alcoholic Liver Disease.Associations Between the Phosphatidylethanol Alcohol Biomarker and Self-Reported Alcohol Use in a Sample of HIV-Infected Outpatient Drinkers in Western Kenya.Phosphatidylethanol (PEth) as a Biomarker of Alcohol Consumption in HIV-Infected Young Russian Women: Comparison to Self-Report Assessments of Alcohol Use.Prevalence of Prenatal Alcohol Exposure in the State of Texas as Assessed by Phosphatidylethanol in Newborn Dried Blood Spot Specimens.The usefulness of biomarkers of alcohol abuse in hair and serum carbohydrate-deficient transferrin: a case report.Feasibility and Acceptability of an Alcohol Addiction Therapy Integrated in a Transplant Center for Patients Awaiting Liver Transplantation.n-Propyl 2,3,4,6-tetra-O-acetyl-β-d-glucopyran-oside.Isopropyl 2,3,4,6-tetra-O-acetyl-β-d-glucopyran-oside.Phosphatidylethanol in Comparison to Self-Reported Alcohol Consumption Among HIV-Infected Women in a Randomized Controlled Trial of Naltrexone for Reducing Hazardous Drinking.Evaluation of biomarkers assessing regular alcohol consumption in an occupational setting.Applications and Challenges for the Use of Phosphatidylethanol Testing in Liver Disease Patients (Mini Review).Urine ethyl glucuronide and ethyl sulphate using liquid chromatography-tandem mass spectrometry in a routine clinical laboratory.Alcohol Biomarkers in Clinical and Forensic Contexts.Sparse canonical correlation analysis between an alcohol biomarker and self-reported alcohol consumption.
P2860
Q26738661-94397601-54ED-48A6-89C4-9C087B471922Q26748593-6CA55108-9E1A-403C-8977-3093CD4FAEF5Q30431186-426B1552-1010-46B5-B33B-2E6AC23F7378Q30834960-7E3FB16F-821D-45BB-9562-7216F0C74DFBQ33579210-3530B448-640F-48DA-B30A-774BF59F732EQ33767799-EB1B1539-4CB6-440E-A6F7-4F859DAFB1F9Q33840930-DCC2C5DA-8B5A-4CBE-989D-45F5241ABB74Q34118694-63FEDE71-F36D-44EC-B0BB-FEAAEFE6817CQ34694013-503B91DA-4DAF-4C5F-88F5-DE9F3AD53CEEQ35449734-6E66FDEC-C85F-468D-8941-85AF0BA0F4BDQ35537874-904BFEFD-E96A-4A31-80D6-A3E4C885BE93Q35546771-7DD9D1E2-444D-486F-A3EE-F7603C6D5F58Q35705286-CEDBFBEB-1038-44FC-B4BE-2B7B6D31D518Q36139051-E7CF0CAD-3A04-4505-A013-962543C4C7B5Q36324039-1A6093DE-8D6C-418D-A6CF-EC87EB49E8E9Q36867713-B179AD4A-AD10-4DB4-A3C1-BED87199BA3BQ37082392-819B1BF1-1378-4E7C-9420-4B074B0FA609Q38071058-90760062-B2D1-4706-9982-2A296D217774Q38669597-0EAAE825-155E-4B68-B755-BE3C30D13C26Q39041281-35BA1866-661A-4FE1-900C-B4F3711E0451Q39593134-8D0C2AD0-2495-4F7B-A70E-08D6E4B1447FQ40237305-70ACAA83-2464-482D-834D-CEBB70CD0377Q40452219-6E248298-6DA8-4CFB-B809-E5A6B8382CF7Q41626784-105C5B9E-04B4-434A-B634-E371DEA82708Q41628238-95D5EE86-D5CB-45F5-9CE2-91EF146659AEQ42156601-79A6AD61-54D1-4A03-9FAC-97C2CFB6FDE7Q43236525-38A4A026-7F47-4E70-B69A-A33481872306Q46412154-919D667E-7139-4319-98CA-8143503EC598Q48167161-275C3CB1-8B4C-49F7-911B-1F7FC679A29BQ48272231-9E6E9A32-BF21-4C55-9646-2B64AC4A1B93Q51532924-A55A9D33-F645-4983-BA35-3F47DB93D2C0Q55098054-15F2DB58-76A8-4981-A794-812FA14EB78EQ55283996-E9CDA581-541C-4279-B27E-6E51ED8F3E78
P2860
Monitoring of the Alcohol Biomarkers PEth, CDT and EtG/EtS in an Outpatient Treatment Setting
description
im Juni 2012 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2012
@uk
name
Monitoring of the Alcohol Biom ...... n Outpatient Treatment Setting
@en
Monitoring of the Alcohol Biom ...... n Outpatient Treatment Setting
@nl
type
label
Monitoring of the Alcohol Biom ...... n Outpatient Treatment Setting
@en
Monitoring of the Alcohol Biom ...... n Outpatient Treatment Setting
@nl
prefLabel
Monitoring of the Alcohol Biom ...... n Outpatient Treatment Setting
@en
Monitoring of the Alcohol Biom ...... n Outpatient Treatment Setting
@nl
P2860
P356
P1476
Monitoring of the Alcohol Biom ...... n Outpatient Treatment Setting
@en
P2093
Oszkár Péter
Yufang Zheng
P2860
P304
P356
10.1093/ALCALC/AGS065
P577
2012-06-12T00:00:00Z